Strategic Partners
Isaac Kaye
Isaac Kaye built Norton Healthcare Limited, a UK generic pharmaceutical company, which was acquired by Ivax Corporation in 1990. Subsequent to the merger, Mr. Kaye continued to lead Norton, as Deputy Chief Executive Officer and Vice Chairman of Ivax, which was later sold to Teva Pharmaceutical Industries in 2006 for $7.4 billion. Mr. Kaye has also been active in promoting Israel-based technology and innovation. He was a co-founder of Israel Healthcare Ventures, a leading Israel-based venture capital firm, and established the Kaye Innovation Awards to encourage and recognize technological achievements at the Hebrew University of Jerusalem. Mr. Kaye is a member of the Board of Directors of Flynn Pharma.
Donald Panoz
Donald Panoz has over 40 years of healthcare operating and investing experience. Dr. Panoz founded Mylan Laboratories in 1960 and served as its President until 1969. He subsequently founded Elan Corporation in 1969 and served as its Chairman and CEO until 1996. Dr. Panoz currently serves or has served on the Board of Directors of Mylan, Elan, Sicor, Warner Chilcott and Sequitor Medical Technologies. Additionally, he has developed and headed global businesses in hospitality, real estate and community development and automotive racing, and has formed, invested in and monetized numerous development-stage companies in healthcare, technology and environmentally friendly technology.
Marvin Samson
Marvin Samson was formerly Group Vice President - Worldwide Injectables of Teva, previously having served as CEO and a member of the Board of Directors of Sicor. He is an expert in injectable manufacturing and delivery systems and was a founder and CEO of Elkins-Sinn (now a division of Baxter Healthcare) and Marsam Pharmaceuticals. He is the founder and CEO of Samson Medical Technologies, a privately held company providing hospital and alternate site pharmacists with injectable drug delivery systems and programs. Mr. Samson is Chairman of The University of Sciences Board of Trustees and serves on the Board of Directors of Trevi portfolio company Flynn Pharma. Mr. Samson served as chairman of the board and CEO of Qualitest Pharmaceuticals from 2007 until purchase by Endo Pharmaceuticals in late 2007 and as the chairman of the Generic Pharmaceutical Industry Association from 1997 to 2000. Mr. Samson is the holder of five U.S. patents pertaining to pharmaceutical manufacturing.